Recent Finacing
Recent Raise
Sionna Therapeutics is a clinical-stage biotech developing small-molecule CFTR modulators for cystic fibrosis, focusing on NBD1 stabilization and complementary ICL4/TMD1 programs, with INDs planned for SION-638 and SION-109.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
